Tarsus Pharmaceuticals In... (TARS)
NASDAQ: TARS
· Real-Time Price · USD
54.17
-0.44 (-0.81%)
At close: Aug 19, 2025, 10:46 AM
Tarsus Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|
| License Fees and Collaboration Revenue | 2.89M | 2.72M | 955K | 2.08M |
| License Fees and Collaboration Revenue Growth | +6.48% | +184.61% | -53.98% | n/a |
| Product Revenue | 180.06M | 14.73M | n/a | n/a |
| Product Revenue Growth | +1122.48% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 103.01M | 85M | 69.03M | 57.91M | 58.79M | 51.58M | 43.01M | 30.32M | 20.27M | 15.1M | 14.63M | 11.99M | 10.38M | 7.95M | 6.77M | 6.67M | 6.79M | 5.16M | 3.89M | 2.15M | 1.53M | 606K | 387K | 234K | 112.25K | 112.25K |
| Selling, General, and Administrative Revenue Growth | +21.20% | +23.13% | +19.20% | -1.50% | +13.99% | +19.93% | +41.82% | +49.56% | +34.31% | +3.16% | +22.00% | +15.59% | +30.58% | +17.34% | +1.51% | -1.81% | +31.67% | +32.65% | +80.93% | +40.89% | +151.82% | +56.59% | +65.38% | +108.46% | 0.00% | n/a |
| Research and Development Revenue | 15.59M | 14.41M | 16.87M | 12.13M | 12.32M | 12.07M | 13.3M | 12.11M | 12.55M | 12.36M | 10.03M | 10.91M | 9.6M | 12.08M | 8.04M | 10.21M | 7.2M | 16.26M | 7.59M | 7.99M | 1.74M | 1.51M | 697K | 399K | 225.25K | 225.25K |
| Research and Development Revenue Growth | +8.22% | -14.60% | +39.12% | -1.55% | +2.10% | -9.31% | +9.91% | -3.52% | +1.54% | +23.21% | -8.10% | +13.63% | -20.51% | +50.30% | -21.27% | +41.71% | -55.70% | +114.33% | -5.06% | +360.05% | +14.88% | +116.93% | +74.69% | +77.14% | 0.00% | n/a |